EISAI GMBH

Italy

All drugs from this manufacturer

  • FYCOMPA

    Fycompa is an antiepileptic used to reduce the number of epileptic seizures in adults, adolescents, and children. It is used to treat both partial seizures (which affect part of the brain) and certain generalized seizures (which affect the whole brain from the onset).

    Dosage form: tablets, film-coated

    Active substance Dosage
    perampanel -

    ATC: N03AX22

  • It is an anticancer drug used in adults to treat metastatic or locally advanced breast cancer (when other therapies have not worked) and advanced or metastatic liposarcoma (a tumor of the fatty tissue) after a previous therapy has been attempted without success.

    Dosage form: solution for injection

    Active substance Dosage
    eribulin -

    ATC: L01XX41

  • Inovelon is an antiepileptic used, together with other medicines, to treat epileptic seizures associated with Lennox-Gastaut syndrome in adults, adolescents, and children from 1 year of age.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rufinamide -

    ATC: N03AF03

  • It is used in combination with other medicines as a first-line treatment for adults with advanced renal cell carcinoma, or in combination with everolimus when other treatments have not been effective.

    Dosage form: capsules, hard gelatin

    Active substance Dosage
    lenvatinib mesilate -

    ATC: L01EX08

  • This medicine is used for the treatment of progressive or advanced thyroid cancer in adults, liver cancer (hepatocellular carcinoma) and, in combination with another drug, advanced endometrial cancer in adult women.

    Dosage form: capsules, hard gelatin

    Active substance Dosage
    lenvatinib -

    ATC: L01EX08

  • It is used to treat mild cognitive impairment or mild dementia caused by Alzheimer's disease in adults.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    lecanemab -

    ATC: N06DX04